Sam Bankman-Fried, the former CEO of FTX, is currently on trial for alleged fraud and market manipulation.

His lawyers have recently raised concerns about his ability to focus during the trial, citing his attention deficit hyperactivity disorder (ADHD) as a contributing factor.

Bankman-Fried has been prescribed Adderall, a medication commonly used to treat ADHD, but his lawyers argue that he needs a higher dose than what he has been receiving.